Menu

Implen Launches New NanoPhotometer N120: The High Throughput Champion!

Implen GmbH is excited to announce the release of the NanoPhotometer® N120, an absorbance based UV/VIS Multi Channel Spectrophotometer.

Jun 7, 2019
Implen, Inc.

The instrument’s extremely compact and stand-alone design (20x20 cm) allows for rapid full scan analysis of up to 12 samples (2µl) at a time over a wide concentration range (2-8,000 ng/μl dsDNA). The N120 provides reliable data for the accurate determination of sample purity ratios, while reducing operational steps for the user by 33%. Powered by a 2.4 GHz Intel Celeron processor, the N120 significantly reduces measurement time providing high resolution full scan data in as little as 1.7 seconds per sample.

The NanoPhotometer® N120 features our unique and proprietary 12 Point Technology™ which consists of several positioning guides for single and multi-channel pipettes, patented illuminated sample windows as well as a software controlled animated sample processing grid to ensure convenient and error free sample application for the user.

Implen’s NPOS is ready for digital transformation by providing various options for database integration utilizing a REST API. The NanoPhotometer® can be easily incorporated into workflows by integration with any major LIMS provider for flexibility and added efficiency. Data export and device control can be executed directly through the LIMS interface on an external computer. 

The N120 can be combined with the new optional CFR21 software package providing FDA 21 CFR Part 11 compliance for electronic records and electronic signatures. This compliancy software, providing user management, is an ideal feature for the Pharmaceutical and Biotechnology industry which rely on proper electronic record keeping and data integrity.  

With the reliability and robust design you’ve come to know and trust, the N120 from Implen is free from recalibration saving the user significant cost over the lifetime of the instrument. 


October 2019

Brain Fog

Air Pollution May Cause Cognitive Decline

Marketplace

Sponsored Product Updates

Lonza’s MODA-ES™ Platform helps Nephron Pharmaceuticals move from paper to an EBR in nine months - Case study to be presented at 2019 ISPE Annual Meeting 
Lonza’s MODA-ES™ Platform helps Nephron Pharmaceuticals move from paper to an EBR in nine months - Case study to be presented at 2019 ISPE Annual Meeting 
·        Lonza has partnered with Nephron Pharmaceuticals Corporation to implement Lonza’s next-generation MODA-ES™ EBR Platform to streamline manufacturing compliance reporting· The MODA-ES™ Platform was implemented at Nephron in an aggressive nine-month time frame, improving operational efficiency and enabling a significant product line expansion·        Full results of the collaboration will be co-presented by Lonza and Nephron at the 2019 ISPE Annual Meeting & Expo in Las Vegas, Nevada
Understanding T-cell polyfunctionality: How single cell proteomics data drive CAR-T cell therapy research and development
Understanding T-cell polyfunctionality: How single cell proteomics data drive CAR-T cell therapy research and development
Vladimir Senyukov, Director of BioAnalytical Development at Precision Biosciences, talks about investigating T-cell cytokine production using single cell proteomics in order to unlock the therapeutic potential of allogenic CAR-T cells.
Zymo Research launches new RNA-Seq library prep kit
Zymo Research launches new RNA-Seq library prep kit
Zymo Research is excited to announce the fastest and easiest total RNA-Seq library prep kit that allows users to go from sample to sequencer in a single day!